FOXM1 and pancreatic neoplasm: Subsequently, we quantified the expression levels of miR-23a in pancreatic tumor samples exhibiting negative/weak, moderate, and strong FOXM1 expression through laser-assisted microdissection-coupled quantitative PCR (Fig. 1A).